| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2022 | Hlavinka Sarah E.70 | Director | Buy | 10,160 | $9.89 | $100,439.70 | +27.0% | -7.0% | +146.6% | ||
| Aug 11, 2022 | RGEN Repligen Corp | Kuriyel Ralf72 | Senior VP, R&D | Sell | 4,840 | $254.32 | $1,230,885.60 | -10.2% | -29.1% | -30.1% | |
| Aug 11, 2022 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Sell | 20,000 | $4.33 | $86,689.19 | -0.8% | -23.0% | -78.6% | |
| Aug 11, 2022 | SRTS Sensus Healthcare, Inc. | Sardano Joseph C81 | Chief Executive Officer | Sell | 158,412 | $14.12 | $2,237,478.46 | -4.1% | -45.8% | -76.1% | |
| Aug 10, 2022 | RDGL Vivos Inc | Korenko Michael K | CEO And President | Buy | 200,000 | $0.07 | $14,000.00 | +2.1% | - | - | |
| Aug 10, 2022 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 112 | $23.17 | $2,595.04 | - | -15.8% | -48.6% | |
| Aug 10, 2022 | Madaus Martin D72 | Director | Buy | 89,667 | $8.43 | $755,543.11 | +54.4% | +9.0% | +182.5% | ||
| Aug 10, 2022 | TELA Tela Bio, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 11,979 | $8.52 | $102,088.63 | +0.7% | -16.7% | +2.6% | |
| Aug 10, 2022 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | VP, Global Human Resources | Sell | 40 | $23.17 | $926.80 | -0.1% | -15.8% | -48.6% | |
| Aug 10, 2022 | BLFS Biolife Solutions Inc | Rice Michael72 | CEO | Sell | 171 | $23.17 | $3,962.07 | - | -15.8% | -48.6% | |
| Aug 10, 2022 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 52 | $23.17 | $1,204.84 | - | -15.8% | -48.6% | |
| Aug 10, 2022 | AXGN Axogen, Inc. | Freitag Gregory Gene68 | Director | Sell | 8,886 | $9.70 | $86,158.66 | -2.4% | +20.6% | -37.5% | |
| Aug 10, 2022 | IART Integra Lifesciences Holdings Corp | Evoli Lisa76 | Executive Vice President &CHRO | Sell | 1,165 | $55.81 | $65,019.58 | -6.1% | -11.8% | -21.2% | |
| Aug 10, 2022 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 42 | $23.17 | $973.14 | -0.1% | -15.8% | -48.6% | |
| Aug 10, 2022 | RMD Resmed Inc | Sandercock Brett63 | Chief Financial Officer | Sell | 2,500 | $240.66 | $601,650.00 | -2.3% | -12.2% | -27.0% | |
| Aug 10, 2022 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality Officer | Sell | 95 | $23.17 | $2,201.15 | - | -15.8% | -48.6% | |
| Aug 10, 2022 | MMSI Merit Medical Systems Inc | Frost Ronald | Chief Operating Officer | Sell | 20,000 | $62.10 | $1,242,000.00 | -56.9% | +9.0% | +10.9% | |
| Aug 10, 2022 | Meister Paul M | Director | Buy | 234,304 | $8.53 | $1,998,313.74 | +105.1% | +9.0% | +182.5% | ||
| Aug 10, 2022 | Walt David R | Director | Buy | 150,000 | $8.62 | $1,293,495.00 | +11.7% | +9.0% | +182.5% | ||
| Aug 10, 2022 | ATEC Alphatec Holdings, Inc. | Pritzker Jennifer N.49 | 10% Owner | Buy | 8,100 | $7.99 | $64,705.00 | +7.8% | +16.9% | +89.0% | |
| Aug 10, 2022 | LMAT Lemaitre Vascular Inc | Pellegrino Joseph P Jr45 | Chief Financial Officer | Sell | 34,738 | $54.26 | $1,884,740.23 | -44.8% | -19.8% | +3.1% | |
| Aug 10, 2022 | SRTS Sensus Healthcare, Inc. | O'Rear Samuel77 | Director | Sell | 50,000 | $14.20 | $710,196.38 | -14.8% | -47.0% | -75.7% | |
| Aug 9, 2022 | BDX Becton Dickinson & Co | Polen Thomas E Jr | Executive Vice President | Sell | 1,652 | $260.00 | $429,520.00 | -5.4% | -13.2% | +11.9% | |
| Aug 9, 2022 | AORT Artivion, Inc. | Maier Dennis B50 | SVP, Operations | Sell | 5,762 | $21.61 | $124,513.00 | -4.4% | -46.8% | -22.3% | |
| Aug 9, 2022 | BDX Becton Dickinson & Co | Khichi Samrat S. | EVP And General Counsel | Sell | 16,480 | $260.44 | $4,292,051.20 | -58.2% | -13.2% | +11.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.